Viewing Study NCT02441569


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-01 @ 1:04 PM
Study NCT ID: NCT02441569
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2015-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Common Engagement Strategies (Common Factors) for Childhood Anxiety
Sponsor: Johns Hopkins Bloomberg School of Public Health
Organization:

Study Overview

Official Title: Common Engagement Strategies (Common Factors) for Childhood Anxiety
Status: COMPLETED
Status Verified Date: 2017-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This trial examines the effectiveness of training pediatric primary care providers (nurse practitioners, doctors) to use of strategies that enhance family/youth empowerment and engagement during office visits for children with mild to moderate problems with anxiety. Children coming for routine care at one clinic are screened for anxiety symptoms and seen by either a specially trained provider or one of the clinic's other regular staff members.
Detailed Description: Children who are thought to have mild to moderate anxiety will, via their parents, be offered the opportunity to receive treatment from their pediatric primary care provider. Providers will either use their existing anxiety approaches or will use those approaches combined with extra communication skills designed to promote patient and parent engagement in care. Children will be seen for up to 4 30-minute visits at 2 week intervals, with a follow-up telephone call 3 months later to asses the impact of treatment. Children with more severe anxiety (or those whose parents so desire) will be referred for specialized mental health care.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: